Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
11/2003
11/25/2003US6653329 Granulated pharmaceutical formulations and methods for making the same
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/20/2003WO2003095432A1 Benzimidazole derivatives
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003032984A8 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
11/20/2003WO2003014079A8 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
11/20/2003US20030216583 Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols
11/20/2003US20030216582 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury
11/20/2003US20030216581 Textile grafted with bactericide
11/20/2003US20030216460 N3 alkylated benzimidazole derivatives as MEK inhibitors
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216405 Hydroxycarbonyl or alkyloxycarbonyl or aminohydroxycarbonyl substituted sulfonamide compounds useful as procollagen C-protenase inhibitor
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030215667 Electroluminescent devices
11/20/2003CA2485753A1 Benzimidazole derivatives
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362043A1 Lactone compounds as novel photoinitiators
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361874A1 Treatment of diseases characterized by excessive or insufficient cell death
11/19/2003EP1144485B1 Method for production of polyelectrolyte membranes and fuel cell
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/18/2003US6649609 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003060956A3 New material for transporting electrons and organic electroluminescent display using the same
11/13/2003WO2003053344A3 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002016327A8 Benzimidazoles and analogues and their use as neutrophil inhibitors
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212120 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
11/13/2003US20030212119 Novel glucagon receptor antagonists/inverse agonists
11/13/2003US20030212070 Dietetics; cardiovascular disorders; hypotensive agents; psychological disorders
11/13/2003CA2484582A1 Bombesin antagonists
11/12/2003EP1359916A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/12/2003EP0880509B1 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant-growth regulators
11/12/2003CN1454891A Benzimidazole and its derivative synthetic method
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645950 Benzimidazole vascular damaging agents
11/11/2003CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003026587A3 Compounds useful for treating hepatitus c virus
11/06/2003US20030207868 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
11/05/2003EP1359139A1 Terphenyl compounds bearing substituted amino groups
11/05/2003EP1358309A1 Composition and method for bleachin g a substrate
11/05/2003EP1358175A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP1019047B1 Antithrombotic agents
11/05/2003EP0902007B1 Chalcone derivatives and drugs containing the same
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/04/2003US6642327 Late transition metal complexes, their use as catalysts and polymers therefrom
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
10/2003
10/30/2003WO2003089425A1 Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-$g(a), $g(a)-dimethyl-benzeneacetic
10/30/2003WO2003088917A2 Regulation of tnf-alpha
10/30/2003WO2003088915A2 Novel sodium channel blockers
10/30/2003WO2003066629A3 Heteroaryl compounds useful as inhibitors of gsk-3
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2003051277A3 Novel compounds
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003CA2482035A1 Novel sodium channel blockers
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003CN1125807C Excitatory amino acid receptor modulators
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638960 Use as microbicides, especially fungicides, in crop protection
10/23/2003WO2003087044A2 Novel carboxamide compounds for use in mch receptor related disorders
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086377A1 Amide derivatives
10/23/2003WO2003086371A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
10/23/2003US20030199580 Condensation of amine derivative with carboxylic acid derivatives to afford intermediate compound, followed by cyclization of intermediate compound in presence of acid; hyopoglycemic action
10/23/2003US20030199564 Indane derivatives
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
10/23/2003US20030199520 Sulfonamide hydroxamates
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1144386B1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
10/22/2003EP1043977B1 Oral pharmaceutical pulsed release dosage form
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2002083608A3 Methods of preparing sulfinamide and sulfoxides
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082826A1 Substituted biaryl amides as c5a receptor modulators
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082186A2 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003US20030191320 Process for the preparation of bis-benzazolyl compounds
10/09/2003US20030191170 Central nervous system disorders; antiallergens; respiratory system disorders
10/09/2003US20030191166 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
10/09/2003US20030191164 Propane-1,3-dione derivatives
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 154